By Dr Michael Lovelace

Conference Abstracts

Gondal K; Lim CK; Hemphill D; Summers BS; Sundaram G; Lovelace MD; Brew B, 2023, 'Neurotoxic kynurenine pathway metabolite quinolinic acid preferentially accumulates in the CSF of progressive MS patients, and localises to cortical neurons, astrocytes, and microglia', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Perth, Vol. 30, pp. 47 - 47, presented at Multiple Sclerosis Australia: Progress in MS Research Conference (MS), AUSTRALIA, Perth, 29 November 2023 - 01 December 2023

Lovelace M; Sardesai V; Varney B; Guillemin GJ; Brew BJ, 2017, 'Laquinimod as a regulator of Kynurenine Pathway in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, Vol. 23, pp. NP27 - NP27, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page